Is radiotherapy good for liver cancer patients

Update Date: 2022-06-11 Source: Network

summary

After a series of examinations, the patient was found to be in advanced stage of liver cancer. Patients with this disease should be treated as soon as possible. Now I will tell you about the treatment of liver cancer.

Is radiotherapy good for liver cancer patients

Treatment 1: targeted therapy is to use an antibody or compound with special affinity for liver cancer as a "carrier", or guide it through physical action, such as magnetism, or guide it through tumor blood vessel specificity, such as Lipiodol, and then combine it with "warheads" (radionuclides, chemotherapeutic drugs, toxin protein, BRM, etc.) with anti-tumor effect, so as to achieve more anti-tumor and less positive damage The purpose of the organization.

Treatment 2: immunotherapy: BCG, Corynebacterium parvum, levamisole, tumor vaccine, embryonic cells, thymosin, transfer factor, immune ribonucleic acid, etc. have been tried in China, but no obvious effect has been achieved.

Treatment 3: anhydrous alcohol injection treatment in recent years, there are many clinical reports of anhydrous alcohol injection under the guidance of B ultrasound in the treatment of liver cancer. This kind of therapy has obvious effect in reducing the focus, controlling and delaying the growth of tumor. Because this therapy does not need special conditions, the operation method is simple, the complications are few, the pain of patients is small, and the cost is low, so it is widely used in clinical practice.

matters needing attention

In clinic, the treatment of advanced liver cancer commonly includes surgery, radiotherapy and chemotherapy, but for patients with advanced liver cancer, the development of the disease and the emergence of complications, the single treatment method has great limitations for the treatment of advanced liver cancer, so it is necessary to formulate the treatment plan of advanced liver cancer combined with the detailed situation of patients, in order to reduce the damage of the disease for patients with advanced liver cancer.